EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...

SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing approval to commence a Phase I clinical trial in Australia (registration number: ...

In its next phase, the Health and Happiness Study aims to collect wellbeing data from over 10,000 global participants using surveys, Garmin smartwatches, and smartphones . OLATHE, ...

Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK facility and provided updates on the ongoing ...

Adolescent BMI amplifies genetic risk for high blood pressure, with sex-specific differences in how BMI modifies SBP ...